Search
Search Results
##search.searchResults.foundPlural##
-
DISTRIBUTION OF DNA DAMAGE REPAIR GENE POLYMORPHISM hOGG1, XRCC1 and p53 AMONG SICKLE CELL DISEASE PATIENTS IN INDIA
1648PDF: 837HTML: 1540Table Genotype and allele frequencies of hOGG1 codon 326 Ser>Cys and p53 72Arg>Pro polymorphisms among SCD patients and control group: 217 -
-
-
A HEALTH RELATED QUALITY OF LIFE AND PSYCHOPATHOLOGICAL SYMPTOMS IN PEOPLE WITH HEMOPHILIA, BLOODBORNE CO-INFECTIONS AND COMORBIDITIES: AN ITALIAN MULTICENTER OBSERVATIONAL STUDY PSYCHOLOGICAL DINAMICS OF A GROUP OF ITALIAN HEMOPHILIACS WITH AND WITHOUT (CO)INFECTIONS AND COMORBIDITIES: A MULTICENTER STUDY
1651PDF: 1300HTML: 537 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4426PDF: 1598HTML: 479 -
The association of rheumatoid arthritis with glucose- 6-phosphate dehydrogenase deficiency—results from a case-control study. G6PD and Rheumatoid Arthritis
1286PDF: 901HTML: 122 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3417PDF: 1001HTML: 4021 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
7145PDF: 3797HTML: 839 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1989PDF: 1076HTML: 253 -
-
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4743PDF: 2025HTML: 18192 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2393PDF: 1877HTML: 993 -
How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency
1915PDF: 963HTML: 1023Referring article: 795 -
DETECTION OF OCCULT GLOMERULAR DYSFUNCTION IN GLUCOSE SIX PHOSPHATE DEHYDROGENASE DEFICIENCY ANEMIA
3856PDF: 1352HTML: 1741Untitled: 208 -
PERPHERAL BLOOD CELL MITOCHONDRIAL DYSFUNCTION IN MYELODYSPLASTIC SYNDROMECAN BE IMPROVED BY A COMBINATION OF COENZYME Q10 AND CARNITINE Blood cell mitochondrial dysfunction in myelodysplastic syndrome
1318PDF: 837HTML: 407 -
PERIOPERATIVE MANAGEMENT OF SICKLE CELL DISEASE: A NARRATIVE REVIEW
10566PDF: 3356HTML: 1642 -
OUTLINE OF IRON METABOLISM, WITH EMPHASIS TO ERYTHROID CELLS iron Metabolism
2476PDF: 1366Html: 1077 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1266PDF: 878HTML: 3420 -
EARLY PREDICTIVE VALUE OF PERIPHERAL INFLAMMATORY INDEX COMBINED WITH HIGH-SENSITIVITY TROPONIN T FOR SEPSIS-INDUCED CARDIOMYOPATHY Inflammatory and Troponon T in cardiomyopaty from Sepsis
389PDF: 399HTML: 208 -
-
AGING WITH THALASSEMIA AND SICKLE CELL DISEASE: A GERONTOLOGICAL MODEL OF ACCELERATED MULTIMORBIDITY AND FUNCTION-CENTERED CARE BEYOND MIDLIFE Thalassemia and Sickle Cell Diseases: Effect of Aging
582PDF: 608Suppl. Files: 79HTML: 167 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2629PDF: 1257HTML: 1088 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
3014PDF: 1032HTML: 7507 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2674PDF: 1662HTML: 720 -
THERAPEUTIC VALUE OF COMBINED THERAPY WITH DEFERASIROX AND SILYMARIN ON IRON OVERLOAD IN CHILDREN WITH BETA THALASSEMIA
2849PDF: 886HTML: 15032Therapeutic Value of Combined Therapy with Deferasirox and Silymarin on Iron Overload in Children with Beta Thalassemia: 361 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3407PDF: 1102HTML: 2504 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5504PDF: 1402HTML: 2880Cover letter: 244







